Metaplastic breast carcinoma: A case report and systematic review of the literature
Authors:
- 25 July 2011
- journal article
- case report
- Published by Wiley in Pathology International
- Vol. 61 (10) , 582-588
Abstract
A 78‐year‐old retired woman was diagnosed with metaplastic breast carcinoma (MBC), a rare tumor, in our hospital. We reviewed 15 articles with a total of 1328 patients to determine the epidemiology, clinical features, biomarkers, histology, management and outcome of patients with this tumor. The mean age at presentation is 58.5 years (range 32–83). Eighty‐one percent of patients presented either with a breast mass or abnormal mammographic finding. Twenty‐three percent of patients had a family history of breast cancer. Estrogen receptors were only found in 12%, progesterone receptors in 10% and HER2 in 6% of patients. The main method of treatment was mastectomy (66.9%) in combination with chemotherapy (57%) and radiotherapy (47%). Five‐year disease‐free survival ranged between 40% and 84% and 5‐year overall survival ranged between 64 and 83%. We have further reviewed the nature of this disease in the light of advancement in genetics, such as microarray gene expression profiling. The relationship of MBC with triple‐negative tumor and basal‐like tumor is discussed. It is hoped that advances in genetics and biomarkers will bring forward the era of personalized medicine in the treatment of breast carcinoma.Keywords
This publication has 26 references indexed in Scilit:
- Biomarkers for Basal-like Breast CancerCancers, 2010
- Carcinosarcoma of the breast: two case reports and review of the literatureCases Journal, 2009
- Triple-Negative Breast Cancer: Risk Factors to Potential TargetsClinical Cancer Research, 2008
- Advances in Breast Cancer: Pathways to Personalized MedicineClinical Cancer Research, 2008
- A case of matrix-producing carcinoma of the breastWorld Journal of Surgical Oncology, 2008
- Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literatureBreast Cancer Research and Treatment, 2006
- Metaplastic carcinoma of the breast Clinical presentation, treatment results and prognostic factorsActa Oncologica, 2006
- A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast CancerNew England Journal of Medicine, 2005
- Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expressionBreast Cancer Research and Treatment, 2005
- Metaplastic breast carcinoma: A cytohistologic and clinical study of 10 casesDiagnostic Cytopathology, 1996